Viatris has submitted an intent-to-use trademark application (TM99714585) to the United States Patent and Trademark Office (USPTO) on March 20, 2026. The application pertains to pharmaceuticals and aims to cover services related to providing information on their diagnostic, prophylactic, and therapeutic properties.

This filing represents a new trademark application and does not impose any immediate compliance obligations on other entities. However, it signifies Viatris's intent to secure trademark protection for its pharmaceutical offerings, which may impact future branding and market positioning within the pharmaceutical sector.